Etana Biotechnologies

Risk score

57
Large logo of Etana Biotechnologies

Headquarters

Flag of IndonesiaIndonesia

Founded in 2014, PT Etana Biotechnologies Indonesia (Etana) is a rising manufacturer of high-quality, cost-effective, and innovative biopharmaceuticals designed to address various metabolic, autoimmune, and other severe life-threatening illnesses, such as cancer. To better cater to the needs of Indonesian patients, Etana has formed a network of strategic partnerships and collaborations with international pharmaceutical producers renowned for their extensive experience in researching and developing safe and effective pharmaceuticals, thus enabling Etana to introduce new treatments to the Indonesian market.